Clinical trial
Study of Itraconazole in Patients With Advanced HIV Infection
NCT00002370 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00002370 |
|---|---|
| Title | Study of Itraconazole in Patients With Advanced HIV Infection |
| Official title | Pharmacokinetics Study of Intravenous Itraconazole Followed by Oral Dosing at 200 Mg Twice Daily in Patients With Advanced HIV Infection |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Itraconazole |
| Enrollment | 36 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: